Kistarcsa, Hungary Clinical Trials

A listing of Kistarcsa, Hungary clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib

This study is designed to evaluate the discontinuation/re-treatment of pexidartinib therapy in previously treated participants with tenosynovial giant cell tumor (TGCT).

Magyar Honvedseg Egeszsegugyi Kozpont
 (9.4 away) Contact site
  • 0 views
  • 30 Jan, 2021
  • +14 other locations
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

This study aims to determine if treatment with apixaban, compared with aspirin, will reduce the risk of ischemic stroke and systemic embolism in patients with device-detected sub-clinical atrial fibrillation and additional risk factors for stroke.

embolism
atrial flutter
diabetes
ischemic stroke
stroke
Magyar Honvedseg Egeszsegugyi Kozpont
 (9.2 away) Contact site
  • 337 views
  • 26 Jan, 2021
  • +131 other locations
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment

The primary purpose of this study is to assess the long-term safety and tolerability of esketamine nasal spray in combination with a selective serotonin reuptake inhibitor/serotonin-norepinephrine reuptake inhibitor (SSRI/SNRI) in participants who have completed 32 weeks of esketamine nasal spray treatment in Study 54135419TRD3013 (NCT04338321).

Ny r Gyula K rh z
 (8.3 away) Contact site
  • 0 views
  • 04 Jun, 2021
  • +54 other locations
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

To evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity

headache
episodic migraine
moderate pain
erenumab
Országos Klinikai Idegtudományi Intézet
 (3.6 away) Contact site
  • 0 views
  • 12 Jun, 2021
  • +107 other locations
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

The purpose of this study is to determine whether intravenous iron supplementation using ferric carboxymaltosis (FCM) reduces hospitalisation and mortality in patients with iron deficiency and heart failure.

heart failure
chronic heart failure
haem
systolic heart failure
iron deficiency anemia
Honv d K rh z
 (9.2 away) Contact site
  • 13 views
  • 25 Jan, 2021
  • +83 other locations
A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against placebo in subjects with chronic migraine (CM) who have a history of at least 1 preventive treatment failure and are diagnosed with medication overuse headache (MOH).

erenumab
acute headache
chronic migraine
headache
hemiplegic migraine
Országos Klinikai Idegtudományi Intézet
 (3.6 away) Contact site
  • 359 views
  • 09 Jun, 2021
  • +167 other locations
Evaluating QTc PK Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML

This is a single-arm, open-label, Phase 4 study evaluating the effect of GO on the QTc, pharmacokinetics, safety, and immunogenicity of GO as a single-agent monotherapy in adult and pediatric patients with relapsed or refractory CD33-positive AML.

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet
 (9.9 away) Contact site
  • 4 views
  • 15 Mar, 2021
  • +40 other locations
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients

This study will explore 2 different doses of inotuzumab ozogamicin including the dose that is approved and a lower dose. The main purpose of this study is to evaluate whether a dose of inotuzumab ozogamicin, lower than the approved dose, could be recommended for adult patient with relapsed or refractory …

kinase inhibitor
cancer
lymphoblasts
serum bilirubin level
blast cells
Del-pesti Centrumkorhaz-Orszagos Hematologiai es Infektologiai Intezet
 (9.9 away) Contact site
  • 178 views
  • 19 Feb, 2021
  • +78 other locations
Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad Dose (CLARIFY MS Extension)

The purpose of the study is the evaluation of the effect of a treatment for highly-active relapsing multiple sclerosis (RMS). This is the extension study to CLARIFY MS (NCT03369665), to assess cognitive impairment and health related quality of life (HRQoL) in participants with highly active RMS, at 4 years after …

relapsing multiple sclerosis
cladribine
Uzsoki Utcai Korhaz
 (7.6 away) Contact site
  • 0 views
  • 04 Jun, 2021
  • +62 other locations